Although TNF‐α antagonism has shown promise in reducing depressive symptoms in chronic inflammatory diseases, there is currently a lack of direct studies exploring the impact of TNF‐α on cognitive impairment in MDD (Bortolato et al., 2015). Here, TNF is linked to major depressive disorder.